26 results
424B3
NTBL
Notable Labs Ltd
5 Sep 23
Prospectus supplement
6:02pm
of quality data sources for the PPMP and raw materials and drug product for clinical development and any commercial sales;
obtaining and maintaining … arrangements with third-party raw materials suppliers and manufacturers;
establishment of arrangements with third-party manufacturers to obtain finished drug
S-4/A
uelbf9ss9jo
30 Jun 23
Registration of securities issued in business combination transactions (amended)
4:38pm
S-4
1tdqjr0g
11 May 23
Registration of securities issued in business combination transactions
9:09am
6-K
EX-99.3
d06 g07xm5
17 May 22
VBL Therapeutics Reports First Quarter 2022 Financial Results
7:00am
424B5
ihaeq9j
11 Feb 22
Prospectus supplement for primary offering
5:28pm
6-K
EX-99.3
hu9bozwcx67t
15 Nov 21
VBL Therapeutics Reports Third Quarter 2021 Financial Results
7:00am
20-F
EX-4.18
zo0yf1iu9
25 Mar 15
Annual report (foreign)
12:00am